ALLEGAN, Mich., Aug. 3 (HSMN NewsFeed) — Perrigo Company (Nasdaq: PRGO; TASE) today announced that its senior partner Teva Pathology Industries Ltd. (Nasdaq: TEVA ; previously Barr Laboratories Inc.) has received final approval from the U.S. Food and Drug…
Biopharmaceuticals, Generics, FDA
Perrigo, Teva Medical, triamcinolone acetonide, NASACORT

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ”
Leave a Comment